China halts work on gene-edited babies

China’s government has ordered a halt to work by a medical team that claimed to have helped make the world’s first gene-edited babies. Leading scientists have declared it’s still too soon to try to make permanent changes to DNA that can be inherited by future generations. Chinese Vice Minister of Science and Technology Xu Nanping… Read More »

Patient-led portal aggregates crowdsourced data to accelerate cancer cure

HealthTree.org, a new patient-led online portal, is aggregating crowdsourced data to accelerate a cure for Multiple Myeloma, a cancer with 30,000 new diagnoses annually that affects bone marrow. The portal aggregates patient-contributed and de-identified data, helps patients find treatment options relevant to them in their specific stage of disease, and connects patients with clinical trials… Read More »

Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model

Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients. ACT is already available in the clinic for some diseases — CAR… Read More »